Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome

Efe, Cumali; Ozaslan, Ersan; KAV, TAYLAN; Purnak, TUĞRUL; Shorbagi, Ali; ÖZKAYAR, ÖZGÜR; Berlot, Alexandra; SÖKMENSÜER, CENK; Muratori, Paolo

doi:10.1016/j.autrev.2011.09.006

Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome

Efe C., Ozaslan E., KAV T., Purnak T., Shorbagi A., ÖZKAYAR Ö., ...More

AUTOIMMUNITY REVIEWS, vol.11, no.5, pp.330-334, 2012 (SCI-Expanded, Scopus)

Publication Type: Article / Review
Volume: 11 Issue: 5
Publication Date: 2012
Doi Number: 10.1016/j.autrev.2011.09.006
Journal Name: AUTOIMMUNITY REVIEWS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.330-334
Open Archive Collection: AVESIS Open Access Collection
Hacettepe University Affiliated: Yes

Abstract

Background and aim: The aim of the present study was to assess the efficacy and tolerability of budesonide as an alternative first line treatment option for autoimmune hepatitis (AIH) and the overlap syndrome.